Last updated: February 23, 2026
What is NDC 59762-1001?
NDC 59762-1001 refers to a specific pharmaceutical product registered with the National Drug Code (NDC) system. Precise identification indicates it is a prescription drug, most likely a branded or generic medication. Detailed information such as active ingredient, dosage form, and labeling is essential but not supplied here.
Market Overview
The drug market surrounding NDC 59762-1001 depends on its therapeutic class, indication, and market demand. Assumed to target a prevalent condition, this drug likely operates within a competitive landscape. The evaluation considers generic availability, patent status, and reimbursement policies.
Key Market Drivers
- Disease prevalence: The target condition’s frequency influences demand. For instance, a chronic illness with high prevalence drives sustainable sales.
- Regulatory environment: FDA approvals, patent protections, exclusivities, and biosimilar entries shape competitive positioning.
- Pricing policies: Medicare, Medicaid, and private payers influence accessible reimbursement levels.
- Manufacturing and supply chain: Capacity to meet demand impacts pricing stability and potential shortages.
Market Size and Demand
Estimating the market size involves analyzing:
- Patient population: Data on diagnosed patients.
- Average treatment duration: Chronic or short-term use.
- Pricing policies: Reimbursement rates vary by region and payer.
For example, assuming a similar drug in its class with 100,000 annual treated patients and an average price per unit of $50, annual revenue could be roughly estimated at $5 million before discounts, rebates, and discounting.
Competitive Landscape
- Similar branded drugs and generics affect pricing.
- Patent protection typically lasts 10-12 years from approval but can be contested.
- Biosimilars or alternative therapies may enter the market, pressing prices downward.
Price Projections
Short-Term (Next 1-2 Years)
- Initial pricing: Established based on the current market environment, possibly ranging from $45-$70 per unit.
- Rebate adjustments: Manufacturers and payers negotiate rebates; these can constitute 20-30% of list prices, reducing net revenue.
- Market entry of generics: If patent expiry occurs within this window, a sharp decline in market price is anticipated.
Medium to Long-Term (3-5 Years)
- Price stabilization: If patent protection persists, prices may stabilize or rise slowly to account for inflation.
- Impact of biosimilars or generics: Expected to lead to price erosion up to 60-70% of original list price over five years post-patent expiry.
- Reimbursement policies: Changes in healthcare policies could influence pricing strategies, especially in public programs.
Comparative Analysis
| Drug Class |
Typical Price Range per Unit |
Patent Status |
Generic Presence |
Expected Price Trend |
| Similar Biologics |
$50 - $150 per dose |
Patent protected |
No |
Stable or increasing |
| Similar Small Molecules |
$20 - $80 per dose |
Patent expiry in 2-5 years |
Multiple generic options |
Decline 50-70% post-expiry |
Regulatory and Policy Considerations
- Pricing regulations: Some jurisdictions regulate high-cost drugs.
- Rebate and discount policies: Growth of managed Medicaid and PBS (Pharmacy Benefit Managers) influence net pricing.
- Therapeutic advancements: New formulations or combination therapies could alter demand and pricing.
Key Risks & Opportunities
- Patent disputes: Could delay generic entry, maintaining higher prices.
- Market penetration: Limited access or reimbursement challenges restrict revenue growth.
- Development of biosimilars: Creates downward pressure but also offers licensing opportunities.
- Emerging competition: Novel therapies in clinical trials may threaten market share.
Summary
NDC 59762-1001 operates amid a competitive landscape shaped by patent status, demand, and policy environment. Short-term prices likely hover around current market levels, with potential for decline post-patent expiry. Long-term pricing depends on generic market entry, regulatory shifts, and advances within its therapeutic class.
Key Takeaways
- The market size hinges on disease prevalence, treatment duration, and reimbursement policies.
- Price projections show limited growth in the short term without patent protection; prices could decline sharply after patent expiration.
- Competition from generics and biosimilars influences long-term market dynamics.
- Regulatory and policy changes remain critical variables in pricing strategies.
- Data gaps, including precise indication, active ingredients, and current patent status, should be filled for a detailed forecast.
FAQs
1. What active ingredient is associated with NDC 59762-1001?
This information requires specific drug labeling data. The NDC code identifies the product but does not specify its active pharmaceutical ingredient without additional context.
2. How soon could patent expiration affect the drug’s price?
Without specific patent data, typical patent life is 10-12 years from approval. If granted recently, patent expiry could be in 3-5 years, potentially leading to price declines.
3. Are biosimilars likely to impact this drug’s market?
If it is a biologic, biosimilar development could reduce prices within 3-5 years post-patent expiry.
4. What factors could cause pricing to increase?
Manufacturing costs, regulatory changes favoring higher reimbursement, or new indications could lead to price increases.
5. How does the competitive landscape influence pricing strategies?
Presence of generics and biosimilars exerts downward pressure, prompting manufacturers to implement rebates or value-based pricing models.
Sources:
[1] U.S. Food and Drug Administration (FDA). (2022). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
[2] IQVIA. (2022). National Prescription Audit.
[3] Medicare.gov. (2022). Prescription drug coverage and costs.
[4] EvaluatePharma. (2022). World Preview - The Top 10 drugs of 2025.
